Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models 论文

2012Cancer Cell引用 378
DOIPDF
Retinoids in leukemia and cellular processesComputational Drug Discovery MethodsMelanoma and MAPK Pathways
Computational Drug Discovery MethodsMelanoma and MAPK PathwaysRetinoids in leukemia and cellular processes
相关技术:Computational Drug Discovery Methods
关系图谱

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models · 相关文章

暂无数据